Brand Premarin (Conjugated Estrogens)
Brand Premarin is the original Pfizer (formerly Wyeth) conjugated estrogens product for hormone replacement therapy in postmenopausal women. Tablets in 0.3mg, 0.625mg and 1.25mg, distinguished from generics by source and certified packaging.
- Active ingredients
- Conjugated Estrogens
- Manufacturer
- Pfizer
- Dosage forms
- tablet
- Available dosages
- 0.3mg, 0.625mg, 1.25mg
- Category
- Hormones and Birth Control
What is it?
Brand Premarin is the original Pfizer (formerly Wyeth) brand of conjugated estrogens, in clinical use since the 1940s. It is one of the longest-established hormone replacement therapy options for postmenopausal women and remains a reference product for HRT prescribing. The product is sourced from pregnant mare urine — a derivation reflected in the brand name (PREgnant MARes' urINe) — and is distinguished from authorised generic conjugated estrogens by source, supply chain and certified packaging.
Active ingredients
Each Brand Premarin tablet contains a defined mixture of conjugated estrogens at 0.3mg, 0.625mg or 1.25mg per tablet. The mixture comprises primarily estrone sulfate (about 50%), equilin sulfate (about 25%), and smaller amounts of other estrogen sulfates. As a hormone replacement therapy, the active mixture restores estrogen receptor signalling lost after menopause. Authorised generic conjugated estrogens contain bioequivalent mixtures from synthetic or alternative sources.
Forms and dosages
Brand Premarin is supplied as oval, biconvex, film-coated tablets in 0.3mg (green), 0.625mg (maroon) and 1.25mg (yellow) strengths. The recommended starting dose for vasomotor symptoms is the lowest dose that controls symptoms, often 0.3mg or 0.625mg daily. Higher doses (1.25mg) are used in selected cases, particularly for osteoporosis prevention. Dosing is typically continuous (daily) or cyclical depending on the regimen and concurrent progestogen use. Tablets can be taken with or without food.
Indications
Brand Premarin is approved for moderate to severe vasomotor symptoms of menopause, vulvovaginal atrophy due to menopause, osteoporosis prevention in postmenopausal women at significant risk, and primary ovarian failure or female hypogonadism. According to current guidelines, hormone therapy is best initiated within 10 years of menopause and before age 60, when the risk-benefit profile is most favourable. The combination with a progestogen is required in women with intact uterus.
How it works
Conjugated estrogens act on estrogen receptors throughout the body. After menopause, the ovaries stop producing estrogen, leading to vasomotor symptoms (hot flashes, night sweats), genitourinary changes (vaginal atrophy, urinary symptoms) and accelerated bone loss. Brand Premarin restores estrogen signalling, addressing these symptoms. The 0.625mg daily dose is considered approximately equivalent to 1mg oral estradiol or 50 mcg transdermal estradiol patch in clinical effect. According to the prescribing information, full vasomotor symptom relief typically develops over 4 to 8 weeks.
Frequently asked questions
What is the difference between Brand Premarin and generic conjugated estrogens? ▾
Brand Premarin is the original Pfizer product, sourced from pregnant mare urine. Authorised generic conjugated estrogens contain a bioequivalent mixture but may use synthetic or alternative sources, and meet the same regulatory bioequivalence requirements. Differences include manufacturer, source, excipients, tablet appearance and price. According to clinical guidelines, an authorised generic is an acceptable substitute for most women. Some patients have animal welfare concerns about the original sourcing and prefer synthetic alternatives.
What dose of Brand Premarin should I start with? ▾
According to the prescribing information, the lowest dose that controls symptoms is preferred. For vasomotor symptoms in early postmenopausal women, 0.3mg or 0.625mg daily is a typical starting dose. Higher doses (1.25mg) may be used in selected patients, particularly for osteoporosis prevention. Dose titration over several weeks, with reassessment of symptom control and side effects, is the standard approach. The decision is made by the prescriber based on symptom severity and individual risk profile.
How long should hormone replacement therapy continue? ▾
Treatment duration is individualised based on symptom severity, ongoing benefit and risk factors. According to current guidelines, the lowest effective dose for the shortest necessary duration is preferred. Many women use HRT for several years to manage menopausal symptoms, with periodic reassessment. Long-term use (>5 years) carries incremental breast cancer risk for combined HRT and should be discussed with the prescriber. There is no mandatory stop date, but regular re-evaluation is essential.
Do I need a progestogen with Brand Premarin? ▾
Women with an intact uterus require concurrent progestogen therapy (continuous or cyclical) to prevent estrogen-driven endometrial hyperplasia and cancer. Pfizer markets Premarin in combination with medroxyprogesterone acetate (Prempro/Premphase) to simplify this. Women without a uterus (after hysterectomy) generally do not require progestogen. According to the prescribing information, omitting progestogen in women with uterus increases endometrial cancer risk substantially, with no benefit to compensate.
What are the most important risks of Brand Premarin? ▾
The main risks include venous thromboembolism (especially with oral routes), increased breast cancer risk with long-term combined therapy, a small increase in stroke risk, and (in women with uterus without progestogen) markedly increased endometrial cancer risk. Cardiovascular benefit observed in observational studies has not been confirmed in randomised trials and depends on age and time since menopause. According to current guidelines, individualised risk-benefit assessment is essential before initiation and during follow-up.
Related medications
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.